Bio Essence Corp (BIOE) stock
BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
$0.42+0.03 (+7.72%)
Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –
Bio Essence operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bio Essence's operating cash flow for the twelve months ending Sep 30, 2026 was $519.88K, down 30.8% year over year. For fiscal 2025 it was $1.57M, up 151.6% from the year before. The highest annual figure on record is $1.57M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.57M | +151.6% |
| FY2024 | Dec 31, 2024 | $623.87K | – |
| FY2023 | Dec 31, 2023 | -$1.03M | – |
| FY2022 | Dec 31, 2022 | -$703.24K | – |
| FY2021 | Dec 31, 2021 | -$1.29M | – |
| FY2020 | Dec 31, 2020 | -$732.74K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$368.85K | -297.3% |
| Q2 FY2026 | Jun 30, 2026 | $59.65K | -64.5% |
| Q1 FY2026 | Mar 31, 2026 | -$411.97K | – |
| Q4 FY2025 | Dec 31, 2025 | $1.24M | +193.3% |
| Q3 FY2025 | Sep 30, 2025 | $186.97K | -47.6% |
| Q2 FY2025 | Jun 30, 2025 | $167.80K | +998.7% |
| Q1 FY2025 | Mar 31, 2025 | -$26.07K | – |
| Q4 FY2024 | Dec 31, 2024 | $423.07K | – |
| Q3 FY2024 | Sep 30, 2024 | $357.14K | – |
| Q2 FY2024 | Jun 30, 2024 | $15.27K | – |
| Q1 FY2024 | Mar 31, 2024 | -$171.61K | – |
| Q4 FY2023 | Dec 31, 2023 | -$204.09K | – |
| Q3 FY2023 | Sep 30, 2023 | -$344.85K | – |
| Q2 FY2023 | Jun 30, 2023 | -$245.01K | – |
| Q1 FY2023 | Mar 31, 2023 | -$231.72K | – |
| Q4 FY2022 | Dec 31, 2022 | -$129.28K | – |
| Q3 FY2022 | Sep 30, 2022 | -$130.28K | – |
| Q2 FY2022 | Jun 30, 2022 | -$189.21K | – |
| Q1 FY2022 | Mar 31, 2022 | -$254.48K | – |
| Q4 FY2021 | Dec 31, 2021 | -$142.57K | – |
| Q3 FY2021 | Sep 30, 2021 | -$173.12K | – |
| Q2 FY2021 | Jun 30, 2021 | -$819.79K | – |
| Q1 FY2021 | Mar 31, 2021 | -$158.64K | – |
| Q4 FY2020 | Dec 31, 2020 | -$236.73K | – |
| Q3 FY2020 | Sep 30, 2020 | -$210.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$227.54K | – |
| Q1 FY2020 | Mar 31, 2020 | -$58.48K | – |
See a number that looks wrong?